A defect in the beta-cells leads to reduced insulin sensitivity and increased insulin resistance, causing a higher insulin demand; clinically observed as hyperinsulinemia during the prediabetic stage (19, 35, 36–38). This evidence concerns the gene INS and Hyperinsulinemia.